HOTAIRM1 can positively regulate IGFBP2 expression, and IGFBP2 binds with HOTAIRM1 via METTL3-mediated m6A binding-domains and increases its stability and expression in glioma tissues and cells. This evidence concerns the gene IGFBP2 and central nervous system cancer.